Katten represented Lumere, a Chicago-based leading provider of technology solutions that drive evidence-based device and drug utilization and purchasing, in its acquisition by Global Healthcare Exchange (GHX), a Colorado-based healthcare company that empowers healthcare organizations to offer better patient care and maximize industry savings. By acquiring Lumere, GHX will expand its portfolio of innovative solutions to help healthcare organizations improve quality of care and efficiency. The acquisition also expands GHX's influence in the pharmaceutical market and allows the company to be a powerful source of trusted information in how to manage devices and drugs used in delivering patient care.
With spending on medical products and drugs becoming one of the fastest growing expenses for US healthcare systems, the combined capabilities of Lumere and GHX will create an industry standard for device and drug intelligence that will optimize patient value.
Hani Elias, CEO of Lumere, expressed his excitement over the merger with GHX and the significant change that the two companies will bring to the healthcare industry.
"Our combined companies will help healthcare stakeholders deliver care that's backed by data and guided by evidence, allowing drug and device expenditures to be supported not just by price but by clinical outcomes. Shining a light on outcomes will provide clinicians and hospital administrators with the information they need to help make the best decisions for every patient," said Elias.
